Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
9 studies found for:    curcumin alzheimer's
Show Display Options
Rank Status Study
1 Unknown  Efficacy and Safety of Curcumin Formulation in Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Dietary Supplement: Curcumin Formulation;   Dietary Supplement: Placebo
2 Completed A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Placebo and ginkgo extract;   Drug: Curcumin and ginkgo extract
3 Completed Curcumin in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Dietary Supplement: Curcumin C3 Complex
4 Recruiting Curcumin and Yoga Therapy for Those at Risk for Alzheimer's Disease
Condition: Mild Cognitive Impairment
Interventions: Drug: Curcumin;   Behavioral: aerobic yoga;   Behavioral: non aerobic yoga;   Dietary Supplement: Placebo
5 Terminated
Has Results
Early Intervention in Mild Cognitive Impairment (MCI) With Curcumin + Bioperine
Condition: Mild Cognitive Impairment
Intervention: Dietary Supplement: curcumin + bioperine
6 Active, not recruiting 18-Month Study of Curcumin
Conditions: Age-associated Cognitive Impairment;   Mild Cognitive Impairment (MCI)
Interventions: Drug: Curcumin;   Other: Placebo
7 Completed Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: Etanercept;   Dietary Supplement: Curcum.Luteol.Theaflav.Lip.Acid,FishOil,Quercet.,Resveratr.
8 Recruiting The Effects of Nanocurcumin on Serum miRNA and Th17 Cells Development Factors in Ankylosing Spondylitis Patients
Condition: Ankylosing Spondylitis
Interventions: Drug: Nanocurcumin;   Drug: Placebo
9 Recruiting The Immunomodulatory Effects of Oral Nanocurcumin in Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Interventions: Drug: Nanocurcumin;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.